Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

212 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
18F-rhPSMA-7 positron emission tomography for the detection of biochemical recurrence of prostate cancer following radical prostatectomy.
Eiber M, Krönke M, Wurzer A, Ulbrich L, Jooß L, Maurer T, Horn T, Schiller K, Langbein T, Buschner G, Wester HJ, Weber WA. Eiber M, et al. J Nucl Med. 2019 Dec 13:jnumed.119.234914. doi: 10.2967/jnumed.119.234914. Online ahead of print. J Nucl Med. 2019. PMID: 31836682
Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer.
Beer AJ, Eiber M, Souvatzoglou M, Holzapfel K, Ganter C, Weirich G, Maurer T, Kübler H, Wester HJ, Gaa J, Krause BJ. Beer AJ, et al. Among authors: Eiber M. Mol Imaging Biol. 2011 Apr;13(2):352-61. doi: 10.1007/s11307-010-0337-6. Mol Imaging Biol. 2011. PMID: 20490932
Radionuclide and hybrid imaging of recurrent prostate cancer.
Beer AJ, Eiber M, Souvatzoglou M, Schwaiger M, Krause BJ. Beer AJ, et al. Among authors: Eiber M. Lancet Oncol. 2011 Feb;12(2):181-91. doi: 10.1016/S1470-2045(10)70103-0. Epub 2010 Jul 6. Lancet Oncol. 2011. PMID: 20599424 Review.
Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions.
Eiber M, Martinez-Möller A, Souvatzoglou M, Holzapfel K, Pickhard A, Löffelbein D, Santi I, Rummeny EJ, Ziegler S, Schwaiger M, Nekolla SG, Beer AJ. Eiber M, et al. Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1691-701. doi: 10.1007/s00259-011-1842-9. Epub 2011 Jun 18. Eur J Nucl Med Mol Imaging. 2011. PMID: 21688050 Clinical Trial.
Simulation of a MR-PET protocol for staging of head-and-neck cancer including Dixon MR for attenuation correction.
Eiber M, Souvatzoglou M, Pickhard A, Loeffelbein DJ, Knopf A, Holzapfel K, Martinez-Möller A, Nekolla SG, Scherer EQ, Schwaiger M, Rummeny EJ, Beer AJ. Eiber M, et al. Eur J Radiol. 2012 Oct;81(10):2658-65. doi: 10.1016/j.ejrad.2011.10.005. Epub 2011 Nov 10. Eur J Radiol. 2012. PMID: 22078793
First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses.
Drzezga A, Souvatzoglou M, Eiber M, Beer AJ, Fürst S, Martinez-Möller A, Nekolla SG, Ziegler S, Ganter C, Rummeny EJ, Schwaiger M. Drzezga A, et al. Among authors: Eiber M. J Nucl Med. 2012 Jun;53(6):845-55. doi: 10.2967/jnumed.111.098608. Epub 2012 Apr 25. J Nucl Med. 2012. PMID: 22534830
Workflow and scan protocol considerations for integrated whole-body PET/MRI in oncology.
Martinez-Möller A, Eiber M, Nekolla SG, Souvatzoglou M, Drzezga A, Ziegler S, Rummeny EJ, Schwaiger M, Beer AJ. Martinez-Möller A, et al. Among authors: Eiber M. J Nucl Med. 2012 Sep;53(9):1415-26. doi: 10.2967/jnumed.112.109348. Epub 2012 Aug 9. J Nucl Med. 2012. PMID: 22879079
212 results
Jump to page
Feedback